The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders

References

• Stein DJ, Scott KM, de Jonge P, Kessler RC. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin Neurosci. 2017;19:127–136.28867937
   PubMed Web of Science ®Google Scholar
• Maron E, Nutt D. Biological predictors of pharmacological therapy in anxiety disorders. Dialogues Clin Neurosci. 2015;17:305–317.26487811
   PubMed Web of Science ®Google Scholar
• Feldman RS. Understanding Psychology. New York: McGraw-Hill; 2011.
   Google Scholar
• Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock’s Synopsis of Psychiatry. New York: Wolters-Kluwer; 2015.
   Google Scholar
• Thibaut F. Anxiety disorders: a review of current literature. Dialogues Clin Neurosci. 2017;19:87–88.28867933
   PubMed Web of Science ®Google Scholar
• Lüthi A, Lüscher C. Pathological circuit function underlying addiction and anxiety disorders. Nat Neurosci. 2014;17:1635–1643. doi:10.1038/nn.384925402855
   PubMed Web of Science ®Google Scholar
• Schiele MA, Domschke K. Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders. Genes Brain Behav. 2018;17:1–15. doi:10.1111/gbb.2018.17.issue-3
   Web of Science ®Google Scholar
• Shimada-Sugimoto M, Otowa T, Hettema JM. Genetics of anxiety disorders: genetic epidemiological and molecular studies in humans. Psychiatry Clin Neurosci. 2015;69:388–401. doi:10.1111/pcn.2015.69.issue-725762210
   PubMed Web of Science ®Google Scholar
• Taylor JM, Whalen PJ. Neuroimaging and anxiety: the neural substrates of pathological and non-pathological anxiety. Curr Psychiatry Rep. 2015;17:49. doi:10.1007/s11920-015-0586-925957101
   PubMed Web of Science ®Google Scholar
• O’Donnell JM, Bies RR, Shelton RC. Drug therapy of depression and anxiety disorders In: Brunton LL, Hilal-Dandan R, Knollmann BC, editors. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2018:267–277.
   Google Scholar
• Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19:93–106.28867934
   PubMed Web of Science ®Google Scholar
• Soeter M, Kindt M. An abrupt transformation of phobic behavior after a post-retrieval amnesic agent. Biol Psychiatry. 2015;78:880–886. doi:10.1016/j.biopsych.2015.04.00625980916
   PubMed Web of Science ®Google Scholar
• Allis CD, Caparros M-L, Jenuwein T, Lachner M, Reinberg D. Overview and concepts In: Allis CD, Caparros M-L, Jenuwein T, Reinberg D, Lachner M, editors. Epigenetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2015:47–115.
   Google Scholar
• Chhabra R. The epigenetics of noncoding RNA In: Tollefsbol TO, editor. Handbook of Epigenetics: The New Molecular and Medical Genetics. Cambridge, MA: Elsevier; 2017:47–59.
   Google Scholar
• Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet. 2012;13:97–109. doi:10.1038/nrg314222215131
   PubMed Web of Science ®Google Scholar
• Peedicayil J, Grayson DR. An epigenetic basis for an omnigenic model of psychiatric disorders. J Theor Biol. 2018;443:52–55. doi:10.1016/j.jtbi.2018.01.02729378208
   PubMed Web of Science ®Google Scholar
• Peedicayil J, Grayson DR. Some implications of an epigenetic-based omnigenic model of psychiatric disorders. J Theor Biol. 2018;452:81–84. doi:10.1016/j.jtbi.2018.05.01429775682
   PubMed Web of Science ®Google Scholar
• Feinberg AP. Epigenetics at the epicenter of modern medicine. JAMA. 2008;299:1345–1350. doi:10.1001/jama.299.11.134518349095
   PubMed Web of Science ®Google Scholar
• Lee R, Avramopoulos D. Introduction to epigenetics in psychiatry In: Peedicayil J, Grayson DR, Avramopoulos D, editors. Epigenetics in Psychiatry. Waltham, MA, USA: Elsevier; 2014:3–25.
   Google Scholar
• Marks IM. Genetics of fear and anxiety disorders. Br J Psychiatry. 1986;149:406–418. doi:10.1192/bjp.149.4.4063545353
   PubMed Web of Science ®Google Scholar
• Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158:1568–1578. doi:10.1176/appi.ajp.158.10.156811578982
   PubMed Web of Science ®Google Scholar
• Bartlett AA, Singh R, Hunter RG. Anxiety and epigenetics. Adv Exp Biol Med. 2017;978:145–166.
   Web of Science ®Google Scholar
• Simmons RK, Howard JL, Simpson DN, Akil H, Clinton SM. DNA methylation in the developing hippocampus and amygdala of anxiety-prone versus risk- taking rats. Dev Neurosci. 2012;34:58–67. doi:10.1159/00033664122572572
   PubMed Web of Science ®Google Scholar
• Zhou R, Chen F, Chang F, Bai Y, Chen L. Persistent overexpression of DNA methyltransferase 1 attenuating GABAergic inhibition in basolateral amygdala accounts for anxiety in rat offspring exposed perinatally to low- dose bisphenol A. J Psychiatr Res. 2013;47:1535–1544. doi:10.1016/j.jpsychires.2013.05.01323791455
   PubMed Web of Science ®Google Scholar
• Zhu C, Liang M, Li Y, Feng X, Hong J, Zhou R. Involvement of epigenetic modifications of GABAergic interneurons in basolateral amygdala in anxiety-like phenotype of prenatally stressed mice. Int J Neuropsychopharmacol. 2018;21:570–581. doi:10.1093/ijnp/pyy00629471396
   PubMed Web of Science ®Google Scholar
• Kosten TA, Huang W, Nielsen DA. Sex and litter effects on anxiety and DNA methylation levels of stress and neurotrophin genes in adolescent rats. Dev Psychobiol. 2014;56:392–406. doi:10.1002/dev.v56.323460384
   PubMed Web of Science ®Google Scholar
• Mccoy CR, Glover ME, Flynn LT, et al. Altered DNA methylation in the developing brains of rats genetically prone to high versus low anxiety. J Neurosci. 2019;39:3144–3158. doi:10.1523/JNEUROSCI.1157-15.201930683683
   PubMed Web of Science ®Google Scholar
• Sagarkar S, Bhamburkar T, Shelkar G, Choudhary A, Kokare DM, Sakharkar AJ. Minimal traumatic brain injury causes persistent changes in DNA methylation at BDNF gene promoters in rat amygdala: a possible role in anxiety-like behaviors. Neurobiol Dis. 2017;106:101–109. doi:10.1016/j.nbd.2017.06.01628663119
   PubMed Web of Science ®Google Scholar
• Moonat S, Sakharkar AJ, Zhang H, Tang L, Pandey SC. Aberrant HDAC2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol Psychiatry. 2013;73:763–773. doi:10.1016/j.biopsych.2013.01.01223485013
   PubMed Web of Science ®Google Scholar
• Suri D, Bhattacharya A, Vaidya VA. Early stress evokes temporally distinct consequences on the hippocampal transcriptome, anxiety and cognitive behaviour. Int J Neuropsychopharmacol. 2014;17:289–301. doi:10.1017/S146114571300100424025219
   PubMed Web of Science ®Google Scholar
• Patki G, Solanki N, Atrooz F, et al. Novel mechanistic insights into treadmill exercise based rescue of social defeat-induced anxiety-like behavior and memory impairment in rats. Physiol Behav. 2014;130:135–144. doi:10.1016/j.physbeh.2014.04.01124732411
   PubMed Web of Science ®Google Scholar
• Kumari A, Singh P, Baghel MS, Thakur MK. Social isolation mediated anxiety like behavior is associated with enhanced expression and regulation of BDNF in the female mouse brain. Phyisiol Behav. 2016;158:34–42. doi:10.1016/j.physbeh.2016.02.032
   Web of Science ®Google Scholar
• Huang S, Dong W, Jiao Z, et al. Prenatal dexamethasone exposure induced alterations in neurobehavior and hippocampal glutamatergic system balance in female rat offspring. Toxicol Sci. 2019;171:369–384. doi:10.1093/toxsci/kfz163
   Web of Science ®Google Scholar
• Viana Borges J, Souza de Freitas B, Antoniazzi V, et al. Social isolation and social support at adulthood affect epigenetic mechanisms, brain-derived neurotrophic factor levels and behavior of chronically stressed rats. Behav Brain Res. 2019;366:36–44. doi:10.1016/j.bbr.2019.03.02530880220
   PubMed Web of Science ®Google Scholar
• Singh S, Siddiqui SA, Tripathy S, et al. Decreased level of histone acetylation in the infralimbic prefrontal cortex following immediate extinction may result in deficit of extinction memory. Brain Res Bull. 2018;140:355–364. doi:10.1016/j.brainresbull.2018.06.00429908895
   PubMed Web of Science ®Google Scholar
• Wang DY, Kosowan J, Samsom J, et al. Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice. Acta Pharmacol Sin. 2018;39:866–874. doi:10.1038/aps.2017.19029417943
   PubMed Web of Science ®Google Scholar
• Cittaro D, Lampis V, Luchetti A, et al. Histone modifications in a mouse model of early life adversities and panic disorder: role for Asic1 and neurodevelopmental genes. Sci Rep. 2016;6:25131. doi:10.1038/srep2513127121911
   PubMed Web of Science ®Google Scholar
• Aten S, Page CE, Kalidindi A, et al. miR-132/212 is induced by stress and its dysregulation triggers anxiety-related behavior. Neuropharmacology. 2019;144:256–270. doi:10.1016/j.neuropharm.2018.10.02030342060
   PubMed Web of Science ®Google Scholar
• Cohen JL, Jackson NL, Ballestas ME, Webb WM, Lubin FD, Clinton SM. Amygdalar expression of the microRNA miR-101a and its target Ezh2 contribute to rodent anxiety-like behaviour. Eur J Neurosci. 2017;46:2241–2252. doi:10.1111/ejn.2017.46.issue-728612962
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu D, Xu J, Jiang H, Pan F. Early adolescent stress-induced changes in prefrontal cortex miRNA-135a and hippocampal miRNA-16 in male rats. Dev Psychobiol. 2017;59:958–969. doi:10.1002/dev.v59.828944448
   PubMed Web of Science ®Google Scholar
• Hoban AE, Stilling RM, Moloney GM, et al. Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. Microbiome. 2017;5:102. doi:10.1186/s40168-017-0321-328838324
   PubMed Web of Science ®Google Scholar
• Spadaro PA, Flavell CR, Widagdo J, et al. Long noncoding RNA-directed epigenetic regulation of gene expression is associated with anxiety-like behavior in mice. Biol Psychiatry. 2015;78:848–859. doi:10.1016/j.biopsych.2015.02.00425792222
   PubMed Web of Science ®Google Scholar
• Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry. 2003;64 Suppl:21–27.12662130
   PubMed Web of Science ®Google Scholar
• Goddard AW, Mason GF, Almai A, et al. Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy. Arch Gen Psychiatry. 2001;58:556–561. doi:10.1001/archpsyc.58.6.55611386984
   PubMed Web of Science ®Google Scholar
• He Y, Ouyang J, Hu Z, et al. Intervention mechanism of repeated oral GABA administration on anxiety-like behaviors induced by emotional stress in rats. Psychiatry Res. 2019;271:649–657. doi:10.1016/j.psychres.2018.12.02530791338
   PubMed Web of Science ®Google Scholar
• Alisch RS, Van Hulle C, Chopra P, et al. A multi-dimensional characterization of anxiety in monozygotic twin pairs reveals susceptibility loci in humans. Transl Psychiatry. 2017;7:1282. doi:10.1038/s41398-017-0047-929225348
   PubMed Web of Science ®Google Scholar
• Domschke K, Tidow N, Schrempf M, et al. Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1(GAD1) DNA hypomethylation?. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:189–196. doi:10.1016/j.pnpbp.2013.07.01423906988
   PubMed Web of Science ®Google Scholar
• Roberts S, Lester KJ, Hudson JL, et al. Serotonin transporter methylation and response to cognitive behaviour therapy in children with anxiety disorders. Transl Psychiatry. 2014;4:e444. doi:10.1038/tp.2014.8325226553
   PubMed Web of Science ®Google Scholar
• Ziegler C, Richter J, Mahr M, et al. MAOA gene hypomethylation in panic disorder- reversibility of an epigenetic risk pattern by psychotherapy. Transl Psychiatry. 2016;6:e773. doi:10.1038/tp.2016.4127045843
   PubMed Web of Science ®Google Scholar
• Shimada-Sugimoto M, Otowa T, Miyagawa T, et al. Epigenome-wide association study of DNA methylation in panic disorder. Clin Epigenetics. 2017;9:6. doi:10.1186/s13148-016-0307-128149334
   PubMed Web of Science ®Google Scholar
• Melas PA, Forsell Y. Hypomethylation of MAOA’s first exon region in depression: a replication study. Psychiatry Res. 2015;226:389–391. doi:10.1016/j.psychres.2015.01.00325623016
   PubMed Web of Science ®Google Scholar
• Ziegler C, Dannlowski U, Braüer D, et al. Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety. Neuropsychopharmacology. 2015;40:1528–1538. doi:10.1038/npp.2015.225563749
   PubMed Web of Science ®Google Scholar
• Sanwald S, Gahr M, Widenhorn-Müller K, et al. Relation of promoter methylation of the oxytocin gene to stressful life events and depression severity. J Mol Neurosci.2020; 70:201–211. doi:10.1007/s12031-019-01446-1
   Web of Science ®Google Scholar
• Murphy TM, O’Donovan A, Mullins N, O’Farrelly C, McCann A, Malone K. Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes. Psychiatr Genet. 2015;25:71–78. doi:10.1097/YPG.000000000000005525350786
   PubMed Web of Science ®Google Scholar
• Tyrka AR, Parade SH, Welch ES, et al. Methylation of the leukocyte glucocorticoid receptor gene promoter in adults: associations with early adversity and depressive, anxiety and substance-use disorders. Transl Psychiatry. 2016;6:e848. doi:10.1038/tp.2016.11227378548
   PubMed Web of Science ®Google Scholar
• Prelog M, Hilligardt D, Schmidt CA, et al. Hypermethylation of FOXP3 promoter and premature aging of the immune system in female patients with panic disorder?. PLoS One. 2016;11:e0157930. doi:10.1371/journal.pone.015793027362416
   PubMed Web of Science ®Google Scholar
• Iurato S, Carrillo-Roa T, Arloth J, et al. DNA methylation signatures in panic disorder. Transl Psychiatry. 2017;7:1287. doi:10.1038/s41398-017-0026-129249830
   PubMed Web of Science ®Google Scholar
• Bortoluzzi A, Salum GA, da Rosa ED, Chagas VD, Castro MAA, Manfro GG. DNA methylation in adolescents with anxiety disorder: a longitudinal study. Sci Rep. 2018;8:13800.30218003
   PubMed Web of Science ®Google Scholar
• Ciuculete DM, Boström AE, Tuunainen A-K, et al. Changes in methylation within the STK32B promoter are associated with an increased risk for generalized anxiety disorder in adolescents. J Psychiatr Res. 2018;102:44–51. doi:10.1016/j.jpsychires.2018.03.00829604450
   PubMed Web of Science ®Google Scholar
• Kang H-J, Kim K-O, Kim J-W, et al. A longitudinal study of the associations of BDNF genotype and methylation with poststroke anxiety. Int J Geriatr Psychiatry. 2019;34:1706–1715. doi:10.1002/gps.v34.1131368178
   PubMed Web of Science ®Google Scholar
• Palma-Gudiel H, Cordova-Palomera A, Tornador C, et al. Increased methylation at an unexplored glucocorticoid responsive element within exon 1D of NR3C1 gene is related to anxious-depressive disorders and decreased hippocampal connectivity. Eur Neuropsychopharmacol. 2018;28:579–588. doi:10.1016/j.euroneuro.2018.03.01529650294
   PubMed Web of Science ®Google Scholar
• Bosmans G, Young JF, Hankin BL. NR3C1 methylation as a moderator of the effects of maternal support and stress on insecure attachment development. Dev Psychol. 2018;54:29–38. doi:10.1037/dev000042229058930
   PubMed Web of Science ®Google Scholar
• Roberts S, Keers R, Breen G, et al. DNA methylation of FKPB5 and response to exposure-based psychological therapy. Am J Med Genet B. 2019;180:150–158. doi:10.1002/ajmg.b.32650
   PubMed Web of Science ®Google Scholar
• Chagnon YC, Potvin O, Hudon C, Préville M. DNA methylation and single nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) genes are associated with anxiety/depression in older women. Front Genet. 2015;30(6):230.
   Google Scholar
• Hommers LG, Richter J, Yang Y, et al. A functional genetic variation of SLC6A2 repressor has-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety. Transl Psychiatry. 2018;8:226. doi:10.1038/s41398-018-0278-430341278
   PubMed Web of Science ®Google Scholar
• Chen SD, Sun XY, Niu W, et al. Correlation between the level of microRNA expression in peripheral blood mononuclear cells and symptomatology in patients with generalized anxiety disorder. Compr Psychiatry. 2016;69:216–224. doi:10.1016/j.comppsych.2016.05.00627423364
   PubMed Web of Science ®Google Scholar
• Dickson DA, Paulus JK, Mensah V, et al. Reduced levels of miRNAs 449 and 34 in sperm of mice and men exposed to early life stress. Transl Psychiatry. 2018;8:101. doi:10.1038/s41398-018-0146-229795112
   PubMed Web of Science ®Google Scholar
• Jacobsen DP, Eriksen MB, Rajalingam D, et al. Exposure to workplace bullying, microRNAs and pain; Evidence of a moderating effect of miR-30c rs928508 and miR-223 rs3848900. Stress. 2020;23:77–86. doi:10.1080/10253890.2019.164232031339402
   PubMed Web of Science ®Google Scholar
• Hettema JM, Otowa T. Genetics of anxiety disorders In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. Philadelphia, PA: Wolters Kluwer; 2017:1737–1741.
   Google Scholar
• Bartlett AA, Lapp HE, Hunter RG. Epigenetic mechanisms of the glucocorticoid receptor. Trends Endocrinol Metab. 2019;30:807–818. doi:10.1016/j.tem.2019.07.00331699238
   PubMed Web of Science ®Google Scholar
• Champagne FA. Beyond the maternal epigenetic legacy. Nat Neurosci. 2018;21:773–774. doi:10.1038/s41593-018-0157-629786084
   PubMed Web of Science ®Google Scholar
• Lee JB, Wei J, Liu W, Cheng J, Feng J, Yan Z. Histone deacetylase 6 gates the synaptic action of acute stress in prefrontal cortex. J Physiol. 2012;590:1535–1546. doi:10.1113/jphysiol.2011.22490722331421
   PubMed Web of Science ®Google Scholar
• Espallergues J, Teegarden SL, Veerakumar A, et al. HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience. J Neurosci. 2012;32:4400–4416. doi:10.1523/JNEUROSCI.5634-11.201222457490
   PubMed Web of Science ®Google Scholar
• Roberts S, Keers R, Lester KJ, et al. HPA axis related genes and response to psychological therapies: genetics and epigenetics. Depress Anxiety. 2015;32:861–870. doi:10.1002/da.2243026647360
   PubMed Web of Science ®Google Scholar
• Hempstead BL. Brain-derived neurotrophic factor: three ligands, many actions. Trans Am Clin Climatol Assoc. 2015;126:9–19.26330656
   PubMedGoogle Scholar
• Suliman S, Hemmings SM, Seedat S. Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci. 2013;7:55. doi:10.3389/fnint.2013.0005523908608
   PubMedGoogle Scholar
• Varela MA, Roberts TC, Wood MJA. Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy. Neurotherapeutics. 2013;10:621–631. doi:10.1007/s13311-013-0212-724068583
   PubMed Web of Science ®Google Scholar
• Murphy CP, Singewald N. Role of microRNAs in anxiety and anxiety-related disorders. Curr Top Behav Neurosci. 2019;42:185–220.31485988
   PubMedGoogle Scholar
• Hadjiargyrao M, Delihas N. The intertwining of transposable elements and non-coding RNAs. Int J Mol Sci. 2013;14:13307–13328. doi:10.3390/ijms14071330723803660
   PubMed Web of Science ®Google Scholar
• Guffanti G, Bartlett A, DeCrescenzo P, Macciardi F, Hunter R. Transposable elements. Curr Top Behav Neurosci. 2019;42:221–246.31605305
   PubMedGoogle Scholar
• Hunter RG, McEwen BS. Stress and anxiety across the lifespan: structural plasticity and epigenetic regulation. Epigenomics. 2013;5:177–194. doi:10.2217/epi.13.823566095
   PubMed Web of Science ®Google Scholar
• Whittle N, Schmuckermair C, Gunduz Cinar O, et al. Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology. 2013;64:414–423. doi:10.1016/j.neuropharm.2012.06.00122722028
   PubMed Web of Science ®Google Scholar
• Sakharkar AJ, Zhang H, Tang L, et al. Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol. 2014;17:1207–1220. doi:10.1017/S146114571400005424528596
   PubMed Web of Science ®Google Scholar
• You C, Zhang H, Sakharkar AJ, Teppen T, Pandey SC. Reversal of deficits in dendritic spines, BDNF and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment. Int J Neuropsychopharmacol. 2014;17:313–322. doi:10.1017/S146114571300114424103311
   PubMed Web of Science ®Google Scholar
• Tran L, Schulkin J, Ligon CO, Greenwood-van Meerveld B. Epigenetic modulation of chronic anxiety and pain by histone deacetylation. Mol Psychiatry. 2015;20:1219–1231. doi:10.1038/mp.2014.122
   Web of Science ®Google Scholar
• Moloney RD, Stilling RM, Dinan TG, Cryan JF. Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition. Neurogastroenterol Motil. 2015;27:1831–1836. doi:10.1111/nmo.1267526403543
   PubMed Web of Science ®Google Scholar
• Sah A, Sotnikov S, Kharitonova M, et al. Epigenetic mechanisms within the cingulate cortex regulate innate anxiety-like behavior. Int J Neuropsychopharmacol. 2019;22:317–328. doi:10.1093/ijnp/pyz00430668714
   PubMed Web of Science ®Google Scholar
• Montagud-Romero S, Cantacorps L, Valverde O. Histone deacetylases inhibitor trichostatin A reverses anxiety-like symptoms and memory impairments induced by maternal binge alcohol drinking in mice. J Psychopharmacol. 2019;33:1573–1587. doi:10.1177/026988111985720831294671
   PubMed Web of Science ®Google Scholar
• Hayase T. Putative epigenetic involvement of the endocannabinoid system in anxiety-and depression-related behaviors caused by nicotine as a stressor. PLoS One. 2016;11:e0158950. doi:10.1371/journal.pone.015895027404492
   PubMed Web of Science ®Google Scholar
• Kv A, Madhana RM, Js IC, Lahkar M, Sinha S, Naidu VGM. Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice. Behav Brain Res. 2018;344:73–84. doi:10.1016/j.bbr.2018.02.00929452193
   PubMed Web of Science ®Google Scholar
• Karnib N, El-Ghandour R, El Hayek L, et al. Lactate is an antidepressant that mediates resilience to stress by modulating the hippocampal levels and activity of histone deacetylases. Neuropsychopharmacology. 2019;44:1152–1162. doi:10.1038/s41386-019-0313-z30647450
   PubMed Web of Science ®Google Scholar
• Park J, Terranova-Barberio M, Zhong AY, Thomas S, Munster PN. Clinical applications of histone deacetylase inhibitors In: Tollefsbol TO, editor. Handbook of Epigenetics: The New Molecular and Medical Genetics. Cambridge, MA: Elsevier; 2017:605–621.
   Google Scholar
• Primeau F, Fontaine R, Beauclair L. Valproic acid and panic disorder. Can J Psychiatry. 1990;35:248–250. doi:10.1177/0706743790035003092111204
   PubMed Web of Science ®Google Scholar
• Keck PE, Taylor VE, Tugrul KC, McElroy SL, Bennett JA. Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry. 1993;33:542–546. doi:10.1016/0006-3223(93)90010-B8513040
   PubMed Web of Science ®Google Scholar
• Woodman CL, Noyes R. Panic disorder: treatment with valproate. J Clin Psychiatry. 1994;55:134–136.8071256
   PubMed Web of Science ®Google Scholar
• Kinrys G, Pollack MH, Simon NM, Worthington JJ, Nardi AE, Versiani M. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol. 2003;18:169–172. doi:10.1097/01.yic.0000064261.66765.9f12702897
   PubMed Web of Science ®Google Scholar
• Aliyev NA, Aliyev ZN. Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study. Eur Psychiatry. 2008;23:109–114. doi:10.1016/j.eurpsy.2007.08.00117945470
   PubMed Web of Science ®Google Scholar
• Bach DR, Korn CW, Vunder J, Bantel A. Effect of valproate and pregabalin on human anxiety-like behaviour in a randomized controlled trial. Transl Psychiatry. 2018;8:157. doi:10.1038/s41398-018-0206-730115911
   PubMed Web of Science ®Google Scholar
• Scott KA, Hoban AE, Clarke G, Moloney GM, Dinan TG, Cryan JF. Thinking small: towards microRNA-based therapeutics for anxiety disorders. Expert Opin Investig Drugs. 2015;24:529–542. doi:10.1517/13543784.2014.997873
   PubMed Web of Science ®Google Scholar
• Roy-Byrne P. Treatment-refractory anxiety; Definition, risk factors, and treatment challenges. Dialogues Clin Neurosci. 2015;17:191–206.26246793
   PubMed Web of Science ®Google Scholar
• Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes In: Allis CD, Caparros M-L, Jenuwein T, Reinberg D, Lachner M, editors. Epigenetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2015:143–168.
   Google Scholar
• Choudhary C, Kumar C, Gnad F, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325:834–840. doi:10.1126/science.117537119608861
   PubMed Web of Science ®Google Scholar
• Dokmanovic M, Marks PA. Prospects: histone deacetylase inhibitors. J Cell Biochem. 2005;96:293–304. doi:10.1002/(ISSN)1097-464416088937
   PubMed Web of Science ®Google Scholar
• Li W, Sun Z. Mechanism of action for HDAC inhibitors – insights from omics approaches. Int J Mol Sci. 2019;20(7):1616. doi:10.3390/ijms20071616
   Web of Science ®Google Scholar
• Guidotti A, Grayson DR. DNA methylation and demethylation as targets for antipsychotic therapy. Dialogues Clin Neurosci. 2014;16:419–429.25364290
   PubMed Web of Science ®Google Scholar
• Wei Y, Melas PA, Wegener G, Mathé AA, Lavebratt C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the BDNF gene. Int J Neuropsychopharmacol. 2014;18(2).
   Web of Science ®Google Scholar
• Peedicayil J, Kumar A. Epigenetic drugs for mood disorders. Prog Mol Biol Transl Sci. 2018;157:151–174.29933949
   PubMed Web of Science ®Google Scholar
• Whittle N, Singewald N. HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?. Biochem Soc Trans. 2014;42:569–581. doi:10.1042/BST2013023324646280
   PubMed Web of Science ®Google Scholar